• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe

Regulatory/Compliance

FDA | Recalls | 510(k) | Pre-Market Approvals | MDSAP | Clinical Trials

Autonomix taps former Medtronic FDA counsel head for board of directors

September 18, 2026 By Conor Hale

Autonomix Medical (Nasdaq:AMIX) has tapped Medtronic’s former chief regulatory counsel, Sandra Cohen Kalter, for its board of directors as it looks to advance its pipeline of catheters for mapping and treating the nervous system. Kalter has served as an advisor to Autonomix’s board for nearly a year. Now with her own seat, the company hopes […]

Filed Under: Business/Financial News, Neurological, Pain Management, Regulatory/Compliance Tagged With: Autonomix, Autonomix Medical, Medtronic, Personnel Moves

Neptune Medical’s robotic colonoscopy system obtains FDA clearance

September 16, 2026 By Conor Hale

Neptune Medical has landed an FDA clearance for its robotic system designed to provide stable control during colonoscopy. The Triton 1 flexible endoscopy system is designed to reach anywhere within the colon for both diagnostic and therapeutic procedures, including screenings for colorectal cancer as well as the removal of early-stage tumors and precancerous growths. According […]

Filed Under: 510(k), Endoscopic, Featured, Food & Drug Administration (FDA), Regulatory/Compliance, Robotic-Assisted, Surgical Robotics Tagged With: bowel cancer, Cancer, Colonoscopy, FDA, Neptune Medical, Robotic Surgery

Medtronic grabs FDA clearance to add LigaSure vessel sealer to Hugo

September 16, 2026 By Conor Hale

Medtronic (NYSE: MDT) has received an FDA green light to bring its vessel-sealing technology over to its Hugo surgical robot, adding to the platform’s U.S. catalog of energy instruments. The agency’s clearance covers the first version of the LigaSure Maryland jaw device designed specifically for robotic-assisted surgery. According to Medtronic, the hand-held vessel sealer has […]

Filed Under: 510(k), Featured, Food & Drug Administration (FDA), Men's Health, Regulatory/Compliance, Robotic-Assisted, Surgical, Surgical Robotics, Urology Tagged With: FDA, Medtronic, Robotic Surgery, surgical robot

Abbott wins FDA approval for Aveir VR Mini ventricular leadless pacemaker

September 15, 2026 By Chris Newmarker

Abbott (NYSE: ABT) announced today that the FDA has approved the smallest version yet of its Aveir leadless pacemakers. The Aveir VR Mini ventricular leadless pacemaker is 32.5 mm long, a 14% reduction from the 38.0 mm of the existing Aveir VR ventricular leadless pacemaker. According to Abbott, it designed the system to deliver longevity […]

Filed Under: Cardiovascular, Featured, Food & Drug Administration (FDA), Pre-Market Approval (PMA), Regulatory/Compliance Tagged With: Abbott

Powerful Medical announces FDA De Novo nod for AI ECG and other extra medtech news

September 15, 2026 By Chris Newmarker

Powerful Medical today announced FDA De Novo authorization for its Queen of Hearts AI ECG model. According to New York–based Powerful Medical, the AI-powered model is meant to identify ECG findings suggestive of urgent acute coronary syndrome (ACS). The goal is to get urgent notifications to clinicians of suspected cases. According to Powerful Medical, the […]

Filed Under: Artificial Intelligence (AI), Cardiovascular, Diagnostics, Digital Health, Food & Drug Administration (FDA), News Well, Pulsed-Field Ablation (PFA), Regulatory/Compliance Tagged With: De Novo Authorization, Edwards Lifesciences, Implicity, Personnel Moves, Powerful Medical, transmedics

XCath Robotics receives FDA breakthrough nod for Iris system

September 15, 2026 By Chris Newmarker

XCath Robotics has FDA Breakthrough Device Designation for its in-development Iris surgical robotic system for mechanical thrombectomy to treat acute ischemic stroke. Houston-based XCath says the designation provides increased opportunities to interact with FDA experts and receive support during the regulatory development and review process for Iris. The designation comes about six months after the […]

Filed Under: Catheters, Food & Drug Administration (FDA), Neurological, Regulatory/Compliance, Robotic-Assisted, Surgical Robotics Tagged With: breakthrough device, XCath Robotics

Intuitive gets expanded indication for da Vinci SP in Europe

September 15, 2026 By Chris Newmarker

Surgical robotics leader Intuitive (NYSE: ISRG) has secured a CE mark covering transvaginal gynecologic procedures for its da Vinci SP surgical system — a world’s first indication for the single-port system. This approval adds to da Vinci SP’s CE-marked existing applications in Europe: endoscopic abdominopelvic, thoracoscopic, transoral otolaryngology, transanal colorectal, and breast surgical procedures. “Building […]

Filed Under: Featured, Gynecological, Regulatory/Compliance, Robotic-Assisted, Surgical Robotics, Women's Health Tagged With: CE Mark, Intuitive, Intuitive Surgical

Beta Bionics insulin patch pump scores FDA clearance

September 15, 2026 By Conor Hale

Beta Bionics (NASDAQ: BBNX) has claimed an FDA clearance for its first patch pump insulin delivery system, amid plans to roll out an updated diabetes dosing algorithm and the launch of a new CGM partnership with Senseonics. The three-day, wearable Mint carries a 200-unit insulin reservoir as well as a combination of reusable and disposable […]

Filed Under: 510(k), Diabetes, Drug Pumps, Drug-Device Combinations, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: Beta Bionics, Senseonics

Luma Vision wins expanded FDA nod for its cardiac procedure software

September 14, 2026 By Chris Newmarker

Luma Vision has won FDA clearance to expand the capabilities of its Verafeye cardiac ablation procedure intelligence platform. The privately held, Dublin, Ireland–based medtech plans to launch commercially in early 2027. The news comes about six months after the company said it was expanding its clinical programs after submitting to the FDA. “By bringing imaging, […]

Filed Under: 510(k), Artificial Intelligence (AI), Cardiovascular, Food & Drug Administration (FDA), Health Technology, News Well, Pulsed-Field Ablation (PFA), Regulatory/Compliance, Software / IT Tagged With: Luma Vision

Johnson & Johnson wins CE mark for new reusable contact lens and other extra medtech news

September 10, 2026 By Chris Newmarker

Johnson & Johnson MedTech (NYSE: JNJ) announced today that it has received a CE mark for its Acuvue Oasys Max 2-Week, a new reusable contact lens. According to J&J, the contact lens features proprietary Max technologies meant to to boost comfort and visual clarity, even at day 14. The company plans to roll out the […]

Filed Under: News Well, Optical/Ophthalmic, Regulatory/Compliance Tagged With: Applied BioCode, CE Mark, CorTec, Getinge, Henry Schein, Johnson & Johnson, Johnson & Johnson MedTech

Ropca wins FDA clearance for ultrasound automation systems

September 9, 2026 By Sophie Carite

Danish medtech company Ropca will bring its autonomous musculoskeletal ultrasound system to the U.S. after receiving FDA 510(k) clearance. The system features two components: Arthur and Diana, which together capture and analyze ultrasound images of finger, hand and wrist joints. Arthur performs standardized musculoskeletal ultrasound scans, and Diana, an AI software, develops AI-assisted analyses and […]

Filed Under: 510(k), Artificial Intelligence (AI), Business/Financial News, Diagnostics, Digital Health, Featured, Food & Drug Administration (FDA), Imaging, Orthopedics, Regulatory/Compliance, Robotic-Assisted, Ultrasound Tagged With: FDA, Ropca

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 860
  • Go to Next Page »

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy